Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2007 | 03-2007 | |
| Operating Expenses | 7,099 | 5,426 |
| Operating Income | -7,099 | -5,426 |
| Interest Expense | 595 | 137 |
| Other Income | 216 | 165 |
| Pre-tax Income | -7,478 | -5,398 |
| Net Income Continuous | -7,478 | -5,398 |
| Net Income | $-7,478 | $-5,398 |
| EPS Basic Total Ops | -12.41 | -9.16 |
| EPS Basic Continuous Ops | -12.41 | -9.16 |
| EPS Diluted Total Ops | -12.41 | -9.16 |
| EPS Diluted Continuous Ops | -12.41 | -9.16 |
| EBITDA(a) | $-6,613 | $-5,404 |